Digital GxP

Digital GxP is a private digital health company offering a software-as-a-service (SaaS) platform aimed at digitizing laboratory and quality processes in the highly regulated pharmaceutical sector. The company targets the critical need for efficient, audit-ready, and compliant documentation, replacing error-prone paper-based systems. By enabling a complete 'paperless' workflow from experiment planning to execution and reporting, Digital GxP helps clients improve data integrity, operational efficiency, and regulatory compliance. As an early-stage company, it is positioned to capitalize on the industry-wide shift towards digitalization and smart manufacturing under the Pharma 4.0 initiative.

A cloud-based, end-to-end digital platform designed to replace paper-based systems in pharmaceutical labs and manufacturing. It facilitates experiment planning, documentation, organization, and reporting with built-in compliance to GxP regulations (e.g., 21 CFR Part 11), supporting the transition to Pharma 4.0.

Digital GxP competes in the laboratory informatics and quality management software market, which is dominated by large players like Thermo Fisher Scientific, Dassault Systèmes (BioVia), LabVantage, and Waters Corporation. It also faces competition from broader electronic lab notebook (ELN) providers and specialized startups. Differentiation must come from user-friendly design, focused pharma compliance, and potentially more agile implementation for mid-market clients.